Federal Trade Commission v. U.S. Anesthesia Partners, Inc. et al.

Docket No.
4:23-cv-03560
District Court
Texas Southern

Goal

  • Block anticompetitive practices

Issues

Case History

Why this Matters 

The Federal Trade Commission alleges that a provider of anesthesia services and a private equity firm violated federal antitrust law by engaging in various practices to consolidate and monopolize the anesthesiology market in Texas. The monopolization of specialty health care services enables providers to maintain greater leverage within the commercial market and further drive up health care costs.  

Potential Impact 

The increasing consolidation of certain health care services by private equity-backed groups and the resulting impact on competition within health care markets could lead to higher costs and lower-quality care for patients.

News And Analysis (2)

64 Major Filings

View More

Related Litigation

Current Status

Briefing is ongoing

Legal Issues

Sherman Act, Clayton Act, Federal Trade Commission Act

Amicus Briefs for Defendant(s)

American Investment Council

Date Filed
September 21, 2023
Case Type
Civil
Court Type
District Court
Court
Texas Southern
Court Division
Houston
Judge
Hoyt, Kenneth M. Appointed By: Ronald Reagan
Plaintiff(s)
Federal Trade Commission
Lead Counsel For Plaintiff(s)
Government
Defendant(s)
U.S. Anesthesia Partners, Inc.; Welsh, Carson, Anderson & Stowe XI, L.P.; WCAS Associates XI, LLC; Welsh, Carson, Anderson & Stowe XII, L.P.; WCAS Associates XII, LLC; WCAS Management Corporation; WCAS Management, L.P.; WCAS Management, LLC
Lead Counsel for Defendant(s)
Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C.